AU2017374947A8 - New anti-angiogenic extracellular vesicles - Google Patents
New anti-angiogenic extracellular vesicles Download PDFInfo
- Publication number
- AU2017374947A8 AU2017374947A8 AU2017374947A AU2017374947A AU2017374947A8 AU 2017374947 A8 AU2017374947 A8 AU 2017374947A8 AU 2017374947 A AU2017374947 A AU 2017374947A AU 2017374947 A AU2017374947 A AU 2017374947A AU 2017374947 A8 AU2017374947 A8 AU 2017374947A8
- Authority
- AU
- Australia
- Prior art keywords
- extracellular vesicles
- new anti
- angiogenic
- evs
- angiogenic extracellular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000001772 anti-angiogenic effect Effects 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention discloses new aiiti-angiogenic extracellular vesicles (extracellular vesicles, EV) formed from stent/stromal mesenchymal cells (also known as mesenchymal stem cells, MSC), said EVs for the treatment of diseases characterized by an increased vascularisation, pharmaceutical compositions comprising the same and methods for the preparation of said EVs.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2016/057608 WO2018109525A1 (en) | 2016-12-14 | 2016-12-14 | New anti-angiogenic extracellurlar vesicles |
AUPCT/IB2016/057608 | 2016-12-14 | ||
PCT/IB2017/057928 WO2018109700A1 (en) | 2016-12-14 | 2017-12-14 | New anti-angiogenic extracellurlar vesicles |
Publications (3)
Publication Number | Publication Date |
---|---|
AU2017374947A1 AU2017374947A1 (en) | 2019-08-01 |
AU2017374947A8 true AU2017374947A8 (en) | 2020-01-16 |
AU2017374947B2 AU2017374947B2 (en) | 2023-08-24 |
Family
ID=57755412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2017374947A Active AU2017374947B2 (en) | 2016-12-14 | 2017-12-14 | New anti-angiogenic extracellular vesicles |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3554513A1 (en) |
CN (1) | CN110312515B (en) |
AU (1) | AU2017374947B2 (en) |
CA (1) | CA3052739A1 (en) |
WO (2) | WO2018109525A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11202111548SA (en) * | 2019-04-18 | 2021-11-29 | Agency Science Tech & Res | Composition |
CN113384597A (en) * | 2020-03-13 | 2021-09-14 | 西比曼生物科技(上海)有限公司 | Aerosol inhalation preparation containing human cell-derived extracellular vesicles, preparation method and application thereof |
WO2021207025A1 (en) * | 2020-04-06 | 2021-10-14 | University Of Georgia Research Foundation, Inc | Mesenchymal cell (msc) exosomes increase t cell differentiation towards t regulatory cells |
EP3909594A1 (en) * | 2020-05-14 | 2021-11-17 | Bernat Soria Escoms | Mesenchymal stromal cells for the treatment of covid-19 and other inflammatory, autoimmune and degenerative diseases |
KR102184428B1 (en) * | 2020-05-25 | 2020-11-30 | 주식회사 씨케이엑소젠 | Method for preparing exosomes from mesenchymal stem cells and culture solution and culture solution produced from the same |
WO2023221987A1 (en) * | 2022-05-16 | 2023-11-23 | 台湾粒线体应用技术股份有限公司 | Composition for alleviating oral damage, use thereof and method for preparing same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8685728B2 (en) * | 2008-01-31 | 2014-04-01 | Rutgers The State University Of New Jersey | Kit containing stem cells and cytokines for use in attenuating immune responses |
KR101640381B1 (en) * | 2008-02-22 | 2016-07-18 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | Mesenchymal stem cell particles |
EP2687219A1 (en) * | 2012-07-18 | 2014-01-22 | Universität Duisburg-Essen | Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions |
PT3027738T (en) * | 2013-08-01 | 2022-05-11 | Swedish Stromabio Ab | Mscs in the treatment of inflammatory pulmonary diseases |
WO2015076717A2 (en) * | 2013-11-21 | 2015-05-28 | Isletone Ab | Mscs in the treatment of cardiac disorders |
CN105861430B (en) * | 2016-04-29 | 2019-07-23 | 南京大学 | A kind of excretion body, the preparation method of excretion body and its application in preparation treatment medication for treating pyemia or preparation |
-
2016
- 2016-12-14 WO PCT/IB2016/057608 patent/WO2018109525A1/en active Application Filing
-
2017
- 2017-12-14 CA CA3052739A patent/CA3052739A1/en active Pending
- 2017-12-14 EP EP17823225.2A patent/EP3554513A1/en active Pending
- 2017-12-14 CN CN201780086372.2A patent/CN110312515B/en active Active
- 2017-12-14 AU AU2017374947A patent/AU2017374947B2/en active Active
- 2017-12-14 WO PCT/IB2017/057928 patent/WO2018109700A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2018109700A1 (en) | 2018-06-21 |
CA3052739A1 (en) | 2018-06-21 |
AU2017374947A1 (en) | 2019-08-01 |
CN110312515A (en) | 2019-10-08 |
WO2018109525A1 (en) | 2018-06-21 |
CN110312515B (en) | 2023-05-16 |
EP3554513A1 (en) | 2019-10-23 |
AU2017374947B2 (en) | 2023-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2021200309B2 (en) | Compositions and methods for treatment of diabetic macular edema | |
AU2017374947A8 (en) | New anti-angiogenic extracellular vesicles | |
MX2019003735A (en) | Dilutable formulations of cannabinoids and processes for their preparation. | |
MY192927A (en) | Fused bicyclic compounds for the treatment of disease | |
MY191581A (en) | Anti-pd-1 antibodies | |
TW201613901A (en) | New compounds | |
PH12017500660A1 (en) | Novel compositions, uses and methods for making them | |
WO2018237037A3 (en) | Anti-bcma heavy chain-only antibodies | |
PH12016501441A1 (en) | Chimeric alkaline phosphate-like proteins | |
WO2018119395A8 (en) | Compounds, compositions and methods of use | |
MX2017008456A (en) | Fused bicyclic compounds for the treatment of disease. | |
EP4292600A3 (en) | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells | |
MY193728A (en) | Muscarinic receptor agonists | |
MX2013000958A (en) | Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma. | |
WO2017223280A3 (en) | Compositions and methods for the delivery of therapeutics | |
MX2021008663A (en) | Improved il-6 antibodies. | |
MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
PH12017500853A1 (en) | Cd44v6-derived cyclic peptides for treating cancers and angionesesis related diseases | |
MX2020002123A (en) | Ribociclib salts and solid state forms thereof. | |
MX370586B (en) | Imidazolyl tricyclic enones as antioxidant iflammation modulators. | |
IN2014CH00840A (en) | ||
MX2017012342A (en) | Fused bicyclic compounds for the treatment of disease. | |
PH12016501613A1 (en) | Pyrazines modulators of gpr6 | |
MX2019004182A (en) | Process for the manufacture of 2,6-dimethyl-5-hepten-1-al. | |
WO2016061555A3 (en) | Novel small molecule anticancer agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TH | Corrigenda |
Free format text: IN VOL 33 , NO 29 , PAGE(S) 4248 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME L'UNIVERSITA DEGLI STUDI DI PADOVA, APPLICATION NO. 2017374947, UNDER INID (71) CORRECT THE APPLICANT NAME TO UNIVERSITA DEGLI STUDI DI PADOVA |
|
DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ NEW ANTI-ANGIOGENIC EXTRACELLULAR VESICLES |
|
FGA | Letters patent sealed or granted (standard patent) |